AVNS CFO reports tax-withholding share disposition

AVANOS MEDICAL, INC.

Rhea-AI Filing Summary

AVANOS MEDICAL, INC. Senior Vice President and Chief Financial Officer Scott Michael Galovan reported a routine tax-related share disposition. On March 9, 2026, 1,119 shares of common stock were surrendered to the company to satisfy tax withholding obligations tied to the vesting of 3,235 time-based restricted share units, each equivalent to one share of common stock. After this tax-withholding transaction, he directly holds 110,343 shares of common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 1,119 shares

Exercise Price or Tax Liability 1 txn

Insider Galovan Scott Michael

Role SVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	1,119	$13.29	$15K

Holdings After Transaction: Common Stock — 110,343 shares (Direct)

Footnotes (1)

1. F1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 3,235 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 7, 2025 and (ii) vested on March 9, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVNS CFO Scott Galovan report in this Form 4?

Scott Galovan reported a tax-withholding disposition of 1,119 shares of AVANOS MEDICAL common stock on March 9, 2026. The shares were surrendered to cover taxes due on vesting restricted share units, not sold in an open-market transaction.

Was the AVNS Form 4 transaction an open-market sale of shares?

No, the AVNS Form 4 transaction was not an open-market sale. The 1,119 shares were surrendered back to the issuer to satisfy tax withholding obligations from vesting restricted share units, a routine administrative event rather than a discretionary share sale.

How many AVNS restricted share units vested for the CFO on March 9, 2026?

A total of 3,235 time-based restricted share units vested for the AVNS CFO on March 9, 2026. Each restricted share unit is economically equivalent to one share of common stock, and part of the resulting shares was used to cover associated tax obligations.

How many AVNS shares does the CFO hold after this Form 4 transaction?

Following the reported tax-withholding disposition, the AVNS CFO directly holds 110,343 shares of common stock. This reflects his remaining position after 1,119 shares were surrendered to the company to cover tax obligations from the vesting of restricted share units.

What does transaction code F mean in the AVNS Form 4 filing?

Transaction code F indicates shares were used to pay the exercise price or tax liability. In this AVNS filing, 1,119 shares were surrendered to meet tax withholding obligations upon vesting of 3,235 time-based restricted share units held by the CFO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 02:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galovan Scott Michael

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

SUITE 100

(Street)

ALPHARETTA GA 30004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		F(1)		1,119	D	$13.29	110,343	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 3,235 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 7, 2025 and (ii) vested on March 9, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John S. Fischer, as attorney-in-fact for Scott M. Galovan	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.